Sword Diagnostics: Empowering Early Detection For Disease

If you think about it, early detection systems are all around us.  How many times have we heard about smoke detectors saving lives, or weather radars detecting potentially dangerous storms?

As you may expect, early detection is nothing new to the medical field.  If you have ever had blood drawn for a test or a screening you are familiar with diagnostic detections.  The problem however, is that many tests remain mostly unchanged since they were developed. This means that some diseases are still being detected at a stage where treatment may be less effective. What if there was earlier detection for health related issues, such as cancer? Sword Diagnostics focuses on the development of next-generation diagnostic disease detection technology.  This technology increases the sensitivity of biomedical tests to detect lower concentrations of biomarkers, which are indicators of disease.  For many diseases early detection means earlier treatment, which greatly increases one’s survival rate.  Additionally, this technology can be used to better monitor the response of the disease to the treatment and allow for adjustments in medical care. Sword’s detection chemistry is compatible with today’s diagnostic tests without need for changes in industry standard procedures or instrumentation.  This greatly increases the potential adoption rate for this new technology. Dave Dingott, President of Sword Diagnostics, said “since beginning sales in February, we have already received commitment from a diagnostics company that screens for breast cancer through a simple blood test.  By incorporating Sword’s chemistry into its test they obtained immediate improvements in sensitivity without requiring the purchase of expensive instrumentation and without requiring the redesign of their test. We intend to partner with additional diagnostics companies with the goal of providing earlier detection for many diseases.” Sword Diagnostics is one of a select group of Illinois companies registered and qualified for the Illinois Angel Investment Credit Program operated by the Illinois Department of Commerce and Economic Opportunity, which allows for tax credits for investors if specific conditions are met.  For more information visit the Illinois Department of Commerce and Economic Opportunity website. Through technological innovations like Sword Diagnostics,  one day we will be able to detect and treat diseases as soon as they emerge.    

Techli

Edward is the founder and CEO of Techli.com. He is a writer, U.S. Army veteran, serial entrepreneur and chronic early adopter. Having worked for startups in Silicon Valley and Chicago, he founded, grew and successfully exited his own previous startup and loves telling the stories of innovators. Email: Edward.Domain@techli.com | @EdwardDomain

Recent Posts

HostMilano 2025: AI and Automation Transform Professional Kitchen Operations

HostMilano 2025 concluded its 44th edition on October 26 and remains the premier world fair…

2 días ago

Prezent AI reaches latest milestone following recognition as top software company in 2025

As the new year approaches, the Software Report—a trusted source for market research and industry…

3 días ago

Ness Digital Engineering and Vendavo to usher in new era of AI-led innovation

Now that AI has been on the scene for a number of years, we can…

3 días ago

AI is reengineering orthopedic systems through new multi-layer software architectures

The rapid evolution of orthopedic technology is no longer being driven by devices alone. Instead,…

2 semanas ago

Digital credentialing enters a new phase with the arrival of I.C.E. Exchange 2025 in Phoenix

The credentialing industry’s calendar is turning toward Phoenix this month, where the I.C.E. Exchange will…

2 semanas ago

Tax season gets an upgrade as Deduction raises $2.8M and launches its AI-powered tax agent

Deduction today announced the launch of “Taylor, CPAI,” the first AI tax accountant built for…

2 semanas ago